2m 2m 2m 2m 2m 2m 2m
BRIDGEBIO PHARMA (BBIO)
NASDAQ
$67.28+$0.37 (+0.55%)
Price as of Oct 02, 2026 4:15 PM EDT- $13.1BMarket Cap
- 25.58%1-Year Change
- BiotechnologyIndustry
BRIDGEBIO PHARMA (BBIO)
$67.28+$0.37 (+0.55%)
BBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $66.91 | ||
Change | +$1.11 (+1.69%) | ||
Open | $65.72 | ||
High | $67.25 | ||
Low | $65.16 | ||
Previous Close | $65.80 | ||
Volume | 3,550,066 | ||
30-Day Average Volume | 2,823,468 | ||
1-Week Change | 0.95% | ||
1-Month Change | -12.62% | ||
1-Year Change | 25.58% | ||
3-Year Change | 153.74% | ||
5-Year Change | 40.16% | ||
Fundamentals | |||
Shares Outstanding | 195.5M | ||
Total Assets | $1.2B | ||
Market Cap | $13.1B | ||
Enterprise Value | $13.0B | ||
Period: QTR TTM FY | |||
Revenue | $222.4M | ||
Net Income | -$155.9M | ||
Free Cash Flow | -$71.5M | ||
EBIT | -$152.0M | ||
EBITDA | -$150.9M | ||
Net Working Capital | $202.5M | ||
EPS | -$0.78 | ||
Enterprise Value/EBITDA | -86 | ||
Enterprise Value/Revenue | 58 | ||
P/B | -5 | ||
P/E | -86 | ||
PEG | -12 | ||
Price/Free Cash Flow | -183 | ||
Price/Operating Cash Flow | -184 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue